More than 1 billion people around the world suffer from chronic pain, which can interfere with quality of life, affect a person's ability to work, and ...

Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, ...

According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

DelveInsight’s, “Neuroendocrine tumors Pipeline Insight” report provides comprehensive insights about 100+ companies and 120+ ...

a kinase inhibitor that inhibits colony-stimulating factor 1 receptor, in patients with a confirmed diagnosis of TGCT with measurable disease per the Response Evaluation Criteria in Solid Tumors ...

Version 1.0, Dated 23/Jul/2024) for weight management before the committee. Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, ...

To study how GLP-1 receptor agonists affect muscle and fat, the HKUMed research team used genetic data of more than 800,000 European participants from different genome-wide association studies (GWAS).

GLP-1 receptor agonists are pharmaceutical treatments primarily for T2D and more recently, obesity. They function by mimicking the action of GLP-1 hormone, which plays a crucial role in ...

Single-cell multiomic analyses reveal known and new genes and pathways involved in the development of germ cells and provide a discovery platform for the scientific community.